Síndrome Antifosfolípido

 

Referencias:
- Schreiber K et al; Antiphospholipid syndrome Nat Rev Dis Primers 2018 Jan 25 4 18005.
- Miyakis S et al; International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome ( J Thromb Haemost 2006 Feb 4 2 295 306.
- Devreese KNJ et al; Laboratory criteria for antiphospholipid syndrome communication from the SSC of the ISTH J Thromb Haemost 2018 Apr 16 4 809 813.
- Shi H et al; Antiphosphatidylserine /prothrombin antibodies aPS / as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome Clin Chem Lab Med 2018 Mar 28 56 4 614 624.
- Sciascia S et al; Anti prothrombin aPT and anti phosphatidylserine/prothrombin sPS / antibodies and the risk of thrombosis in the antiphospholipid syndrome A systematic review Thromb Haemost 2014 Feb 111 2 pp 354 364.
- Sciascia S et al; Reliability of lupus anticoagulant and anti phosphatidylserine/prothrombin autoantibodies in antiphospholipid syndrome a multicenter study Front Immunol 2019 Mar 5 10 376.
- Sciascia S et al; Diagnosing antiphospholipid syndrome ::“extra criteria” manifestations and technical advances Nat Rev Rheumatol 2017 Sep 13 9 548 560.
- Tektonidou MG etal; EULAR recommendations for the management of antiphospholipid syndrome in adults. Annals of the Rheumatic Diseases 2019;78:1296-1304.

Artículos recientes

Síndrome antifosfolípido: el punto de vista Médico

Únase a nosotros para una presentación con Ware Branch, MD, Universidad de Utah.

Actualización Síndrome AntiFosfolípidos

Infografía sobre Criterios de Clasificación 2023 ACR/EULAR SAF

Diagnóstico de SAF y aPS/PT.

Trombosis Vascular: Al menos 1 episodio de trombosis arterial, venosa o de pequeño vaso en cualquier órgano o tejido

© Copyright - 2026 - TeamAID . Todos los derechos reservados. Política de privacidad
Desarrollado por: